Cefdinir
- Product NDC
- 68180-722
- 11-digit product format
- 681800722
- Labeler code
- 68180
- Product ID
- 68180-722_b32b7bfb-4770-4da0-8c48-684233cd10c9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Lupin Pharmaceuticals, Inc.
- Application
- ANDA065259
- Marketing category
- ANDA
- Marketing start
- 2006-05-31
- Substance
- CEFDINIR
- Active strength
- 125 mg/5mL
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cefdinir
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CEFDINIR | 125 mg/5mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | CI0FAO63WC |
| Rxcui | 309054, 476576 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68180-722-04 | Cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | | 9 |
| 68180-722-05 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 9 |
| 68180-722-10 | Cefdinir | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | | 9 |
| 68180-722-20 | Cefdinir | 60 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 60 | | 9 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFDINIR | ACTIVE INGREDIENT | CI0FAO63WC | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| CEFDINIR | ACTIVE MOIETY | CI0FAO63WC | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| CITRIC ACID | INACTIVE INGREDIENT | 2968PHW8QP | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| COLLOIDAL SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| GUAR GUM | INACTIVE INGREDIENT | E89I1637KE | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| SODIUM CITRATE | INACTIVE INGREDIENT | 1Q73Q2JULR | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| STRAWBERRY | INACTIVE INGREDIENT | 4J2TY8Y81V | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | CEFDINIR (CEFDINIR) POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS INC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68180-722 | CEFDINIR POWDER, FOR SUSPENSION [LUPIN PHARMACEUTICALS, INC.] | 8 | Current NDC, Legacy NDC, 4 package rows | 20250130_7490df67-56c0-4a1c-8533-2107f3e8aea5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68180-722-04 | 68180072204 | 60 mL in 1 BOTTLE (68180-722-04) | 60 ml | 2020-05-22 | 0000-00-00 | No | No | Current |
| 68180-722-05 | 68180072205 | 100 mL in 1 BOTTLE (68180-722-05) | 100 ml | 2020-05-22 | 0000-00-00 | No | No | Current |
| 68180-722-10 | 68180072210 | 100 mL in 1 BOTTLE (68180-722-10) | 100 ml | 2006-05-31 | 2022-01-31 | No | No | Current |
| 68180-722-20 | 68180072220 | 60 mL in 1 BOTTLE (68180-722-20) | 60 ml | 2007-05-07 | 2022-01-31 | No | No | Current |